Creating Biomedical Technologies to Improve Health

NEWS & EVENTS

March 8, 2013

Brain scan + genome screening IDs Alzheimer’s risk gene by Lisa Fratt, HealthImaging

Genomic screening in combination with MRI imaging has enabled NIBIB-funded researchers at the University of California Los Angeles (UCLA) to discover genetic varients that affect the brain’s wiring. The findings suggest that a specific gene (SPON1) variant and new neurogenetic pathway have links to dementia severity. Additional information can be found from Proceedings of the National Academy of Sciences: Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity.